Adrenal cortex adenylate cyclase. Specific binding sites for 5'-guanylyl-imidodiphosphate in partially purified plasma membranes from bovine adrenal cortex
- PMID: 1186917
- DOI: 10.1007/BF00498032
Adrenal cortex adenylate cyclase. Specific binding sites for 5'-guanylyl-imidodiphosphate in partially purified plasma membranes from bovine adrenal cortex
Abstract
Specific binding sites for 5'-guanylyl-imidodiphosphate [Gpp(NG)p] have been identified in a partially purified plasma membrane fraction from bovine adrenal cortex. The apparent affinity of Gpp(nh)p at 30 degrees C was 12muM-1 and the concentration of binding sites was 100 pmoles per mg of protein. Binding of Gpp(NH)p is inhibited by Mn2+ greater than Mg2+ greater than Ca2+ and enhanced by low concentrations of the chelators ethylenediamino-tetraacetic acid (EDTA) and ethylene glycolbis-(beta-aminoethylether))-N,N'-tetraacetic acid (EGTA). High concentrations of EDTA are inhibitory and at 2.5 mM EDTA binding of Gpp(NH)p is only 10% of that observed in the absence of the chelator. The bound labeled GTP analogue exchanged only slowly with the unlabeled nucleotide after a steady state has been reached. EDTA also releases the bound labeled Gpp(NH)p from its binding sites. The slow dissociation of Gpp(NH)p can explain the persistent activation of adenylate cyclase observed after pretreatment of bovine adrenal cortex plasma membranes with Gpp(NH)p and subsequent washing. It is suggested that at least parts of these binding sites are identical to the sites identified earlier as regulatory sites for angiotensin high-affinity receptors (Glossmann et. al., 1974a) and for ACTH-stimulated cyclase Glossmann and Gips, 1974).
Similar articles
-
Adrenal cortex adenylate cyclase: solubilization of adenylate cyclase and guanyl nucleotide binding sites.Naunyn Schmiedebergs Arch Pharmacol. 1975;291(1):89-100. doi: 10.1007/BF00510823. Naunyn Schmiedebergs Arch Pharmacol. 1975. PMID: 172809
-
Bovine adrenal cortex adenylate cyclase: properties of the particulate enzyme and effects of guanyl nucleotides.Naunyn Schmiedebergs Arch Pharmacol. 1975;289(1):77-97. doi: 10.1007/BF00498031. Naunyn Schmiedebergs Arch Pharmacol. 1975. PMID: 171590
-
Activation of adrenal adenylate cyclase by guanine nucleotides. Promotion of nucleotide binding by calcium but not by adrenocorticotropic hormone.Mol Pharmacol. 1983 Mar;23(2):369-77. Mol Pharmacol. 1983. PMID: 6300646
-
The hepatic adenylate cyclase system. I. Evidence for transition states and structural requirements for guanine nucloetide activiation.J Biol Chem. 1975 Jun 10;250(11):4239-45. J Biol Chem. 1975. PMID: 1126949
-
Adrenal cortex adenylate cyclase. In vitro acitivity of ACTH fragments and analogues.Naunyn Schmiedebergs Arch Pharmacol. 1976 Aug;294(2):199-206. doi: 10.1007/BF00507854. Naunyn Schmiedebergs Arch Pharmacol. 1976. PMID: 189224
Cited by
-
Adrenal cortex adenylate cyclase: solubilization of adenylate cyclase and guanyl nucleotide binding sites.Naunyn Schmiedebergs Arch Pharmacol. 1975;291(1):89-100. doi: 10.1007/BF00510823. Naunyn Schmiedebergs Arch Pharmacol. 1975. PMID: 172809
-
Catecholamine-sensitive adenylate cyclase of caudate nucleus and cerebral cortex. Effects of guanine nucleotides.Biochem J. 1977 Apr 15;164(1):67-74. doi: 10.1042/bj1640067. Biochem J. 1977. PMID: 18147 Free PMC article.
-
Alpha noradrenergic receptors in brain membranes: sodium, magnesium and guanyl nucleotides modulate agonist binding.Naunyn Schmiedebergs Arch Pharmacol. 1979 Jan;306(1):67-73. doi: 10.1007/BF00515595. Naunyn Schmiedebergs Arch Pharmacol. 1979. PMID: 218121 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Miscellaneous